Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

122.42 USD +1.62 (+1.34%)
Streaming Delayed Price Updated: 12:08 PM EST, Feb 24, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
75 76 Next >
Giving Kids With Heart Failure a Brighter Future
Tags NYSE:ABT Wellness Responsible Business & Employee Engagement
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Proceeds from The LightBoard Depot Sales will Support Arts for Better Tomorrow (ABT) in Hollywood
Tags business/economy education c:canada
From EIN Presswire
Abbott Declares 389th Consecutive Quarterly Dividend
The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 45 cents per share. 
From PR Newswire
Breaking Down Barriers, Advancing Health Equity
Tags Health & Healthcare COVID Disease Awareness
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Surmodics Reports First Quarter Fiscal 2021 Results
Surmodics Reports First Quarter Fiscal 2021 Results 
From Business Wire News Releases
How Biotech Developers Are Working Towards New Diagnostic Solutions to Help Combat Covid-19
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
How Biotech Developers Are Working Towards New Diagnostic Solutions to Help Combat Covid-19
FN Media Group Presents USA News Group News Commentary 
From PR Newswire
Consumer Health Trends are Fueling an Infant Nutrition Surge
FN Media Group Presents Microsmallcap.com Market Commentary 
From PR Newswire
Consumer Health Trends are Fueling an Infant Nutrition Surge
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Easterseals and the Abbott Fund Join Together to Advance Health Equity Through the Black Child Fund
Tags Easterseals Black Child Fund Abbott Easterseals
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Time to Bridge the Gap, Demand Diabetes Care Equity
Tags Disease Awareness Abbott Social Innovation
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Abbott Reports Fourth-Quarter 2020 Results; Issues Strong Double-Digit Growth Forecast for 2021
- Sales of $10.7 billion, including $2.4 billion of COVID-19 diagnostic testing-related sales 
From PR Newswire
Abbott's Panbio Rapid Antigen Test Receives CE Mark for Asymptomatic Screening and Self-Administered Sample Collection with Nasal Swab
- Panbio™ COVID-19 Ag Rapid Test Device supports mass testing in congregate populations of people (mass screening) who are asymptomatic 
From PR Newswire
Consumers Continue Flocking to Immune-Boosting Supplements as Health Crisis Rage On
The health crisis has completely changed life as we know it and caused a significant shift in consumer demand for immune-boosting products, vitamins, and supplements. Now, due to growing awareness... 
From PR Newswire
Consumers Continue Flocking to Immune-Boosting Supplements as Health Crisis Rage On
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
12-Month Data from Surmodics’ TRANSCEND Trial Presented at LINC 2021 Event
12-Month Data from Surmodics’ TRANSCEND Trial Presented at LINC 2021. SurVeil™ Drug-Coated Balloon (DCB) demonstrates non-inferior safety and efficacy 
From Business Wire News Releases
Abbott's BinaxNOW, FreeStyle Libre 2 Win BIG Innovation Honors
Tags Corporate Governance Awards, Ratings & Rankings NYSE:ABT
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Abbott Receives Expanded Medicare Reimbursement for First-Of-Its-Kind MitraClip™ Device
- New national reimbursement enables access to transcatheter mitral valve repair procedures with MitraClip for people with secondary mitral regurgitation, significantly expanding the eligible patient... 
From PR Newswire
Abbott Receives FDA 510(K) Clearance for the First Rapid Handheld Blood Test for Concussions
Tags Public Health Health & Healthcare TBI
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Abbott to Launch the NeuroSphere™ myPath™ Digital Health App Designed to Track and Report Pain Relief in Chronic Pain Patients With Physicians Prior to Device Implant
- New app will allow patients to record their pain relief during the device trial period with spinal cord stimulation or dorsal root ganglion therapy, simplify reporting outcomes and connect patients... 
From PR Newswire
Why There's Still Need for Rapid Accessible Pathogen Testing, During and After the Crisis
As the most at-risk people begin to receive COVID-19 vaccinations, we are all looking forward to a post-pandemic world. As we transition back to something closer to normal life, however, the importance... 
From PR Newswire
Abbott Announces Fulfillment of Federal Government Purchase of 150 Million BinaxNOW™ COVID-19 Rapid Tests and Is Now Ready to Support Commercial Distribution
- Abbott will complete the U.S. government order for 150 million BinaxNOW COVID-19 tests this week and will supply 30 million additional tests through March via a new government order 
From PR Newswire
Abbott Receives FDA 510(k) Clearance for the First Rapid Handheld Blood Test for Concussions
- The test to help evaluate mild traumatic brain injury (TBI), commonly known as concussion, produces a result within 15 minutes after a plasma sample is inserted and will run on Abbott's i-STAT™... 
From PR Newswire
Abbott Hosts Conference Call for Fourth-Quarter Earnings
Abbott (NYSE: ABT) will announce its fourth-quarter 2020 financial results on Wednesday, Jan. 27, 2021, before the market opens. 
From PR Newswire
As Vaccines Roll Out, Americans See COVID-19 Testing as Important Partner
- 88% of Americans say it's important for COVID-19 testing to work in support of vaccine rollout 
From PR Newswire
FDA Approves Labeling Update for Abbott's Heartmate 3 Heart Pump for Use in Pediatric Patients
Tags Technology Industry News Abbott's Heartmate 3 Heart Pump Public Health
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Abbott to Present at J.P. Morgan Healthcare Conference
Abbott (NYSE: ABT) will present virtually at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 12, 2021. Robert B. Ford, president and chief executive officer, will present at 9 a.m.... 
From PR Newswire
FDA Approves Labeling Update for Abbott's HeartMate 3 Heart Pump for use in Pediatric Patients
- Abbott's HeartMate 3™ heart pump approved for use for pediatric patients battling advanced heart failure 
From PR Newswire
Abbott's BinaxNOW COVID-19 Rapid Test Receives FDA Emergency Use Authorization for First Virtually Guided, At-Home Rapid Test Using eMed's Digital Health Platform
- First at-home, virtually guided service to bring rapid, reliable and affordable testing into the home where the result is delivered in minutes 
From PR Newswire
Abbott Receives CE Mark for its COVID-19 IgG Quantitative Antibody Blood Test
- SARS-CoV-2 IgG II Quant antibody test measures levels of IgG antibodies to help measure and understand a person's immune response 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
75 76 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.